These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11909755)

  • 21. Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta Mouse).
    Hakura A; Tsutsui Y; Sonoda J; Kai J; Imade T; Shimada M; Sugihara Y; Mikami T
    Mutat Res; 1998 Feb; 398(1-2):123-30. PubMed ID: 9626972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Nitrosodi-n-propylamine induces organ specific mutagenesis with specific expression times in lacZ transgenic mice.
    Itoh S; Miura M; Itoh T; Miyauchi Y; Suga M; Takahashi Y; Kasahara Y; Yamamura E; Hirono H; Shimada H
    Mutat Res; 1999 Aug; 444(2):309-19. PubMed ID: 10521671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocarcinogen 4-methylquinoline induced G:C to C:G transversions in the cII gene in the liver of lambda/lacZ transgenic mice (Muta™Mouse).
    Kitamura Y; Suzuki T; Kohara A; Saeki KI
    Mutat Res; 2020; 821():111709. PubMed ID: 32497932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.
    Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J
    Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation induction by N-propyl-N-nitrosourea in eight MutaMouse organs.
    Hara T; Hirano K; Hirano N; Tamura H; Sui H; Shibuya T; Hyogo A; Hirashio T; Tokai H; Yamashita Y; Kura K
    Mutat Res; 1999 Aug; 444(2):297-307. PubMed ID: 10521670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta Mouse).
    Suzuki T; Hayashi M; Wang X; Yamamoto K; Ono T; Myhr BC; Sofuni T
    Mutat Res; 1997 Dec; 395(1):75-82. PubMed ID: 9465915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the lacZ and cII genes of Muta Mouse.
    Hashimoto K; Ohsawa K; Kimura M
    Mutat Res; 2004 Jun; 560(2):119-31. PubMed ID: 15157650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice.
    Shane BS; Smith-Dunn DL; de Boer JG; Glickman BW; Cunningham ML
    Mutat Res; 2000 Sep; 452(2):197-210. PubMed ID: 11024479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
    Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
    Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple organ mutation in the lacZ transgenic mouse (Muta mouse) 6 months after oral treatment (5 days) with benzo[a]pyrene.
    Hakura A; Tsutsui Y; Sonoda J; Mikami T; Tsukidate K; Sagami F; Kerns WD
    Mutat Res; 1999 May; 426(1):71-7. PubMed ID: 10320752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
    Davies R; Gant TW; Smith LL; Styles JA
    Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
    Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of cII gene mutation in the brains of Big Blue mice exposed to acrylamide and glycidamide in drinking water.
    Li HF; Shelton SD; Townsend TA; Mei N; Manjanatha MG
    J Toxicol Sci; 2016; 41(6):719-730. PubMed ID: 27853100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethyl nitrosourea and methyl methanesulfonate mutagenicity in sperm and testicular germ cells of lacZ transgenic mice (Muta Mouse).
    Suzuki T; Itoh S; Takemoto N; Yajima N; Miura M; Hayashi M; Shimada H; Sofuni T
    Mutat Res; 1997 Feb; 388(2-3):155-63. PubMed ID: 9057876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is MutaMouse insensitive to clastogens?
    Lynch AM; Mahabir AG; Bradford A; Brockhurst K; van Benthem J; van Steeg H; Rees RW
    Mutat Res; 2008 Apr; 652(2):145-50. PubMed ID: 18387845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of lacZ mutation by 7,12-dimethylbenz[a]anthracene in various tissues of transgenic mice.
    Hachiya N; Yajima N; Hatakeyama S; Yuno K; Okada N; Umeda Y; Wakata A; Motohashi Y
    Mutat Res; 1999 Aug; 444(2):283-95. PubMed ID: 10521669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The application of the restriction site mutation assay to compare 1-ethyl-1-nitrosourea-induced mutations between the endogenous p53 gene and the transgenic LacZ gene in MutaMouse testes.
    Song HL; Jenkins GJ; Ashby J; Tinwell H; Parry JM
    Mutagenesis; 2001 Jan; 16(1):59-64. PubMed ID: 11139599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaMouse.
    Smith CC; Archer GE; Forster EJ; Lambert TR; Rees RW; Lynch AM
    Environ Mol Mutagen; 1999; 34(2-3):131-9. PubMed ID: 10529737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
    Besaratinia A; Bates SE; Pfeifer GP
    Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.